Visualisation of tissue kallikrein, kininogen and kinin receptors in human skin following trauma and in dermal diseases
-
Elisabeth Schremmer-Danninger
Abstract
During dermal injury and inflammation the serine proteases kallikreins cleave endogenous, multifunctional substrates (kininogens) to form bradykinin and kallidin. The actions of kinins are mediated by preferential binding to constitutively expressed kinin-B2 receptors or inducible kinin-B1 receptors. A feature of the kinin-B1 receptors is that they show low levels of expression, but are distinctly upregulated following tissue injury and inflammation. Because recent evidence suggested that kinin-B1 receptors may perform a protective role during inflammation, we investigated the specific occurrence of the kallikrein-kinin components in skin biopsies obtained from normal skin, patients undergoing surgery, basalioma, lichenificated atopic eczema, and psoriasis. The tissue was immunolabelled in order to determine the localisation of tissue pro-kallikrein, kallikrein, kininogen and kinin receptors. The kinin components were visualised in normal, diseased and traumatised skin, except that no labelling was observed for kininogen in normal skin. Of the five types of tissue examined, upregulation of kinin-B1 receptors was observed only in skin biopsies obtained following surgery. In essence, the expression of kinin-B1 receptors did not appear to be enhanced in the other biopsies. Within the multiple steps of the inflammatory cascade in wound healing, our results suggest an important regulatory role for kinin-B1 receptors during the first phase of inflammation following injury.
References
Bockmann, S., and Paegelow, I. (2000). Kinins and kinin receptors: importance for the activation of leukocytes. J. Leukoc. Biol.68, 587–59210.1189/jlb.68.5.587Search in Google Scholar
Bhoola, K.D., Figueroa, C.D., and Worthy, K. (1992). Bioregulation of kinins: kallikreins, kininogens and kininase. Pharmacol. Rev.44, 1–80.Search in Google Scholar
Campbell, C.J., Dixon, B., Kladis, A., Kemme, M., and Santamaria, J.D. (2001). Activation of the kallikrein-kinin system by cardiopulmonary bypass in humans. Am. J. Physiol. Regul. Integr. Comp. Physiol.28, R1059–1070.10.1152/ajpregu.2001.281.4.R1059Search in Google Scholar
Chai, K.X., Ni, A., Wang, D., Ward, D.C., Chao, J., and Chao, L. (1996). Genomic DNA sequence, expression, and chromosomal localisation of the human B1 bradykinin receptor gene BDKRB1. Genomics31, 51–57.10.1006/geno.1996.0008Search in Google Scholar
Figueroa, C.D., Henderson, L.M., Kaufmann, J., de la Cadena, R.A., Colman, R.W., Müller-Esterl, W., and Bhoola, K.D. (1992). Immunovisualisation of high (HK) and low (LK) molecular weight kininogens on isolated human neutrophils. Blood79, 754–759.10.1182/blood.V79.3.754.754Search in Google Scholar
Figueroa, C.D., Stuardo, M., Gonzales, C.B., Nualart, F., Corthorn, J., and Bhoola, K.D. (1999). Hydrolysis of kininogens by degranulated human neutrophils and analysis of bradykinin as chemotactic factor for cells isolated from peripheral blood. Immunopharmacology43, 211–217.10.1016/S0162-3109(99)00092-2Search in Google Scholar
Haasemann, M., Figueroa, C.D., Henderson, L., Grigoriev, S., Abd Alla, S., Gonzalez, C.D., Dunia, I., Hoebeke, K., Jarnagin, K., Cartaud, J., et al. (1994). Distribution of bradykinin B2 receptors in target cells of kinin action. Visualisation of the receptor protein in A431 cells, neutrophils and kidney section. Braz. J. Med. Biol. Res.27, 1739–1756.Search in Google Scholar
Kemme, M., Podlich, D., Raidoo, D.M., Snyman, C., Naidoo, S., and Bhoola, K.D. (1999). Identification of immunoreactive tissue prokallikrein on the surface membrane of human neutrophils. Biol. Chem.380, 1321–1328.10.1515/BC.1999.168Search in Google Scholar PubMed
Marceau, F., Hess, J.F., and Bachvarov, D.R. (1998). The B1 receptors for kinins. Pharmacol. Rev.50, 357–386.Search in Google Scholar
Naidoo, Y., Snyman, C.J,. Raidoo, K.M., Bhoola, K.D., Kemme, M., and Müller-Esterl, W. (1999). Cellular visualisation of tissue pro-kallikrein in human neutrophils and myelocytes. Br. J. Haematol.105, 599–612.10.1046/j.1365-2141.1999.01391.xSearch in Google Scholar PubMed
Neppl, H., Neuhof, H., Afflerbach, F., Llach Puig Neppl, J. and Berghofer, A. (1991). Bradykinin-induced oedema formation proceeds from B2 receptor stimulation and is potentiated by concomitantly released prostaglandins. Acta Physiol. Scand.142, 141–147.10.1111/j.1748-1716.1991.tb09141.xSearch in Google Scholar PubMed
Neuhof, C., Walter, O., Dapper, F., Bauer, J., Zickmann, B., Fink, E., Tillmanns, H., and Neuhof, H. (2003). Bradykinin and histamine generation with generalized enhancement of microvascular permeability in neonates, infants, and children undergoing cardiopulmonary bypass surgery. Pediatr. Crit. Care Med.4, 299–304.10.1097/01.PCC.0000074264.13983.99Search in Google Scholar PubMed
Poblete, M.T., Reynolds, N.J., Figueroa, C.D., Burton, J.L., Müller-Esterl, W. and Bhoola, K.D. (1991). Tissue kallikrein and kininogen in human sweat glands and psoriatic skin. Br. J. Dermatol.124, 236–241.10.1111/j.1365-2133.1991.tb00567.xSearch in Google Scholar PubMed
Rawlingson, A., Gerard, N.P., and Brain, S.D. (2001). Interactive contribution of NK(1) and kinin receptors to the acute inflammatory oedema observed in response to noxious heat stimulation: studies in NK(1) receptor knockout mice. Br. J. Pharmacol.134, 1805–1813.10.1038/sj.bjp.0704436Search in Google Scholar PubMed PubMed Central
Regoli, D., and Barabé, J. (1980). Pharmacology of bradykinin and related kinins. Pharmacol. Rev.32, 1–46.Search in Google Scholar
Santos, D.R., Calixto, J.B. and Souza, G.E. (2003). Effect of a kinin B2 receptor antagonist on LPS- and cytokine-induced neutrophil migration in rats. Br. J. Pharmacol.139, 271–278.10.1038/sj.bjp.0705236Search in Google Scholar
Schremmer-Danninger, E., Heinz-Erian, P., Toepfer-Petersen, E., and Roscher, A.A. (1995). Autoradiographic localisation and characterisation of bradykinin receptors in human skin. Eur. J. Pharmacol.283, 207–216.10.1016/0014-2999(95)00347-NSearch in Google Scholar
Schremmer-Danninger, E., Hermann, A., Fink, E., Fritz, H., and Roscher, A.A. (1999). Identification and occurrence of m-RNAs for components of the kallikrein-kinin system in human skin and in skin diseases. Immunopharmacology43, 287–291.10.1016/S0162-3109(99)00100-9Search in Google Scholar
Snyman, C.J., Raidoo, D.M., and Bhoola, K.D. (1999). Localisation of proteases and peptide receptors by confocal microscopy. Methods Enzymol.307, 368–394.10.1016/S0076-6879(99)07024-XSearch in Google Scholar
© Walter de Gruyter
Articles in the same Issue
- Hiroshi Maeda – 40 years of research
- Activation of the kallikrein-kinin system and release of new kinins through alternative cleavage of kininogens by microbial and human cell proteinases
- Molecular mechanism for activation and regulation of matrix metalloproteinases during bacterial infections and respiratory inflammation
- Role of bacterial proteases in pseudomonal and serratial keratitis
- Cysteine cathepsins in human cancer
- Secretory leukoprotease inhibitor and pulmonary surfactant serve as principal defenses against influenza A virus infection in the airway and chemical agents up-regulating their levels may have therapeutic potential
- Design of inhibitors against HIV, HTLV-I, and Plasmodium falciparum aspartic proteases
- Roles of Arg- and Lys-gingipains in coaggregation of Porphyromonas gingivalis: identification of its responsible molecules in translation products of rgpA, kgp, and hagA genes
- Coordinate expression of the Porphyromonas gingivalis lysine-specific gingipain proteinase, Kgp, arginine-specific gingipain proteinase, RgpA, and the heme/hemoglobin receptor, HmuR
- Genetic characterization of staphopain genes in Staphylococcus aureus
- Visualisation of tissue kallikrein, kininogen and kinin receptors in human skin following trauma and in dermal diseases
- Reduction of myocardial infarction by calpain inhibitors A-705239 and A-705253 in isolated perfused rabbit hearts
- A proteinase inhibitor from Caesalpinia echinata (pau-brasil) seeds for plasma kallikrein, plasmin and factor XIIa
- Plasma prekallikrein/kallikrein processing by lysosomal cysteine proteases
- Characteristics of the caspase-like catalytic domain of human paracaspase
- mRNA expression analysis of a variety of apoptosis-related genes, including the novel gene of the BCL2-family, BCL2L12, in HL-60 leukemia cells after treatment with carboplatin and doxorubicin
- Thermoplasma acidophilum TAA43 is an archaeal member of the eukaryotic meiotic branch of AAA ATPases
- Lipopolysaccharide binding of an exchangeable apolipoprotein, apolipophorin III, from Galleria mellonella
Articles in the same Issue
- Hiroshi Maeda – 40 years of research
- Activation of the kallikrein-kinin system and release of new kinins through alternative cleavage of kininogens by microbial and human cell proteinases
- Molecular mechanism for activation and regulation of matrix metalloproteinases during bacterial infections and respiratory inflammation
- Role of bacterial proteases in pseudomonal and serratial keratitis
- Cysteine cathepsins in human cancer
- Secretory leukoprotease inhibitor and pulmonary surfactant serve as principal defenses against influenza A virus infection in the airway and chemical agents up-regulating their levels may have therapeutic potential
- Design of inhibitors against HIV, HTLV-I, and Plasmodium falciparum aspartic proteases
- Roles of Arg- and Lys-gingipains in coaggregation of Porphyromonas gingivalis: identification of its responsible molecules in translation products of rgpA, kgp, and hagA genes
- Coordinate expression of the Porphyromonas gingivalis lysine-specific gingipain proteinase, Kgp, arginine-specific gingipain proteinase, RgpA, and the heme/hemoglobin receptor, HmuR
- Genetic characterization of staphopain genes in Staphylococcus aureus
- Visualisation of tissue kallikrein, kininogen and kinin receptors in human skin following trauma and in dermal diseases
- Reduction of myocardial infarction by calpain inhibitors A-705239 and A-705253 in isolated perfused rabbit hearts
- A proteinase inhibitor from Caesalpinia echinata (pau-brasil) seeds for plasma kallikrein, plasmin and factor XIIa
- Plasma prekallikrein/kallikrein processing by lysosomal cysteine proteases
- Characteristics of the caspase-like catalytic domain of human paracaspase
- mRNA expression analysis of a variety of apoptosis-related genes, including the novel gene of the BCL2-family, BCL2L12, in HL-60 leukemia cells after treatment with carboplatin and doxorubicin
- Thermoplasma acidophilum TAA43 is an archaeal member of the eukaryotic meiotic branch of AAA ATPases
- Lipopolysaccharide binding of an exchangeable apolipoprotein, apolipophorin III, from Galleria mellonella
